Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Sequel (fka Introvoke)
United States
- San Francisco
- 24/08/2022
- Series A
- $8,000,000
Sequel (fka Introvoke) is the only no-code/low-code solution to enable brands to easily build their own live events experiences and engage their communities on their own websites. Hybrid, Virtual and Networking stellar experiences, all embedded in your own branded digital home.
The no-code solution empowers marketers to drive high value actions and increase website traffic. The low-code solution empowers developers to build a sophisticated virtual platforms in just a few days.
- Industry IT Services and IT Consulting
- Website https://www.sequel.io/
- LinkedIn https://www.linkedin.com/company/sequelio/
Related People
Oana ManolacheFounder
United States -
San Francisco Bay Area
Founder of @sequel, ex @HP. Growing an awesome team with the purpose of providing organizations of all sizes with the ability to fully realize the future of work and connectivity.
Expert and keynote speaker at global events with a focus on innovation, the importance of consumer engagement in a B2B environment, women in technology and entrepreneurship.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)